Sabinsa’s proprietary formulation Macumax® was shown to have vision health benefits in a clinical trial on subjects diagnosed with age-related macular degeneration (AMD). The study An Open-Label Pilot Study on Macumax Supplementation for Dry-Type Age-Related Macular Degeneration authored by Muhammed Majeed, Shaheen Majeed and Kalyanam Nagabhushanam, was published in the Journal of Medicinal Food (ahead of print doi.org/10.1089/jmf.2020.0097).
Dr. Muhammed Majeed, Founder and Chairman, Sami-Sabinsa Group was honored with a lifetime achievement award in recognition of his exemplary services in the nutraceuticals and cosmeceuticals industry by ASSOCHAM (The Associated Chambers of Commerce and Industry of India). The award was presented as part of Ayush Mela, one of India’s largest exhibition and conference events related to Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homeopathy (AYUSH).
Dr. Muhammed Majeed, Founder and Chairman, Sami-Sabinsa Group has recently published the fourth book in a series on derivatives of Boswellia serrata.
- Press Release
Sabinsa, a pioneer in the nutraceutical and cosmeceutical industry, has provided documentation to appropriate government agencies in its continuing efforts to identify and remove adulterated vitamin C additives from the market, a practice to which Sabinsa alerted the industry earlier this year.
Sabinsa, a pioneer in nutraceutical and cosmeceutical industry, is offering glyphosate test results to customers, using a proprietary method for testing glyphosate developed by scientists at parent company Sami-Sabinsa. In October they began testing for residual herbicide in 20 nutraceutical ingredients as a routine practice, along with all other USP listed pesticides, and are widening the scope to all products the company sells. Spices must be below 7 ppm and herbs below 0.2 ppm.